AI-generated summary
The authors studied a 660 nm continuous wave laser therapy in rats with spinal cord injury, varying the number of treatment days and the daily dose. They report that movement and pain improvements stopped when treatment ended at week 2, and that longer daily irradiation was associated with better movement scores, especially early on. The authors conclude that treatment duration matters most for mobility and daily dose matters most for pain relief.
- Who or what was studied
- Rats with spinal cord injury
- Wavelengths
- 660 nm
- Limits stated in the abstract
- The study was conducted in rats, so the findings may not apply directly to humans.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm
- Power
- 100 mW
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Laser, Photobiomodulation, Dose, Oxidative stress. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.